A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.
about
DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer.Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.Diagnostic potential of circulating nucleic acids for oncology.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyComparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancerDetection of hypermethylated vimentin in urine of patients with colorectal cancer.Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-AnalysisUtility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer.Role of specific DNA mutations in the peripheral blood of colorectal cancer patients for the assessment of tumor stage and residual disease following tumor resection.Proteomic methodologies and their application in colorectal cancer research.Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.Circulating and stool nucleic acid analysis for colorectal cancer diagnosis.Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer.Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.Future perspectives of circulating tumor DNA in colorectal cancer.Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.Modified PNA-PCR method: a convenient and accurate method to screen plasma KRAS mutations of cancer patients.Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.Oncogenic transformation induced by cell-free nucleic acids circulating in plasma (genometastasis) remains after the surgical resection of the primary tumor: a pilot study.A rat virus visits the clinic: translating basic discoveries into clinical medicine in the 21st century.KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.Novel blood test to predict neoplastic activity in healthy patients and metastatic recurrence after primary tumor resection.Colorectal cancer: using blood samples and tumor tissue to detect K-ras mutations.Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer.Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysisAssessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction
P2860
Q27336155-760D5B82-A306-470B-AE27-E9A880DC63CFQ33679614-075184C3-E6EB-4FF4-BA8C-3BF0CCE17793Q34634536-E0667045-6386-462B-908E-C24EAC51C05FQ35183642-A834F265-897D-4BFA-B753-2F24BB5311EBQ35543094-CC8481F9-6F8F-42E4-BFB7-C77A4CC58C69Q35576801-7E7E2891-49E4-49DD-A2AF-1A004B97D242Q35951870-06B4C92A-61B3-4723-82EF-14077006D52FQ36277022-4F7F3076-4338-440F-B1A3-7ABBC13CB4C7Q36286368-2F2E6962-3AEC-4AD6-8416-507F9023BBBBQ36292534-63266E5B-3691-4B4F-A1A3-F9B8A1BD3DE5Q36475875-6219653B-552A-4625-98BC-F84BDDFB3C4CQ37014663-13974157-3555-4DE9-94FC-82B994A61859Q37015727-641637AE-7D49-4CA7-AD6A-CCE2BC26B015Q37098291-611A4065-0BC3-429C-B1EB-67C343968591Q37406942-2A1F463C-9B68-409A-BD57-0388D0C2D7BEQ37643738-533BB508-C699-4A31-A4BF-62B74D2CA878Q37960201-4F9E6C18-6CBB-4DBD-8254-34EF07CC12BFQ38122618-BF37F0E0-E299-46F7-9E17-FBB2EBA7AC7EQ38191574-6A875E47-893C-4392-BFC7-419B345EB0C9Q38375059-2C090CC2-5A60-452D-AB4B-76490F07A9D0Q38664513-E1063AC6-9173-49EB-8599-4809965822F1Q38685749-3680CE5E-AD0E-416C-8544-2887A223C36EQ39051797-C0A6FE02-7B7B-4B9F-B59A-839B5F3FBB3DQ39400627-95824436-15E5-4BE3-B6D2-4CBEEC239037Q42687570-2B9FFC2B-C8D3-496A-9059-73006AFE86A9Q42835096-4658AC08-5DCB-4AE9-8761-8C0E2DFEB330Q43005891-33855775-3866-4A76-ADF4-762C35A4B42AQ48181330-85FED034-01E6-4902-B4EA-EF30D05B6A8FQ53063259-833A24FC-155A-4534-9FF6-F0AEA973E493Q53482447-BE7D6E16-B8DF-4380-A834-AEC9B796D4AAQ55210260-B78F113E-1021-4285-818F-263721EFCC3CQ57110507-8668EF8C-598E-4A26-8B07-C44F0262E873Q57170570-043C7207-FDBE-4C52-BF28-921E2CCF6B09
P2860
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
A prospective study of circula ...... or in postoperative follow up.
@ast
A prospective study of circula ...... or in postoperative follow up.
@en
type
label
A prospective study of circula ...... or in postoperative follow up.
@ast
A prospective study of circula ...... or in postoperative follow up.
@en
prefLabel
A prospective study of circula ...... or in postoperative follow up.
@ast
A prospective study of circula ...... or in postoperative follow up.
@en
P2093
P2860
P356
P1433
P1476
A prospective study of circula ...... tor in postoperative follow up
@en
P2093
P2860
P304
P356
10.1136/GUT.52.1.101
P407
P577
2003-01-01T00:00:00Z